FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 78058

Company■ Unclear/unknown

Phase 3 results posted: An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product — Good Molecules, LLC

KINDCompany
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Small cosmetic trial results posted; minimal investable relevance.

Small hyperpigmentation trial results posted
CATALYST TO WATCH

Product launch or marketing claims

MAIN RISK

Tiny enrollment limits significance

FULL DISPATCH

Sponsor: Good Molecules, LLC; Status: Completed; Conditions: Hyperpigmentation; Interventions: Facial Toner, Placebo Toner; Enrollment: 49 (actual); First posted: 2025-08-22; Results posted: 2026-10-13; NCT: NCT07136766

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDConsumer

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01clinicaltrialsclinicaltrials.gov · PRIMARY2026-10-13 12:00 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.